TAXUS LIBERTE PACLITAXEL-ELUTING CORONARY STENT SYSTEM
Report
- Report Number
- 2134265-2011-01924
- Event Type
- Death
- Date Received
- May 24, 2011
- Date of Event
- April 23, 2011
- Report Date
- April 26, 2011
- Manufacturer
- BOSTON SCIENTIFIC - GALWAY
- Product Code
- NIQ
- PMA / PMN Number
- P060008
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- IN
- Reporter Occupation
- PHYSICIAN
Narratives
DEVICE IS A COMBINATION PRODUCT. DEVICE EVALUATED BY MANUFACTURER - IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED. (B)(4).
IT WAS REPORTED THAT POST A STENTING TREATMENT PROCEDURE, A PATIENT DEATH OCCURRED. THE 80% STENOSED, 3.0X35MM CONCENTRIC DE NOVO LESION BEING TREATED CONTAINED A >45 DEGREE AND <90 DEGREE BEND AND WAS LOCATED IN THE NON-TORTUOUS, MILD TO SEVERELY CALCIFIED PROXIMAL LEFT ANTERIOR DESCENDING (LAD) ARTERY. THE LESION WAS PREDILATED WITH AN UNSPECIFIED BALLOON AND THE PHYSICIAN DEPLOYED A 3.0X38MM TAXUS LIBERTE STENT. THE STENT WAS WELL APPOSED. MEDICATIONS GIVEN: CLOPIDOGREL, ASPIRIN, AND EPTIFIBATIDE. THREE DAYS POST THE STENTING PROCEDURE, THE PATIENT EXPERIENCE CHEST PAIN. IN-STENT THROMBOSIS WAS IDENTIFIED IN THE PREVIOUSLY IMPLANTED STENT. A NON-BSC CATHETER WAS USED TO REMOVE THE THROMBUS. PATIENT DEATH OCCURRED THE SAME DAY.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | TAXUS LIBERTE PACLITAXEL-ELUTING CORONARY STENT SYSTEM | CORONARY DRUG-ELUTING STENT | NIQ | BOSTON SCIENTIFIC - GALWAY | H7493894038300 | 0013412986 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 52 YR | Death |